Back to South Dakota

HB1099 • 2026

reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Last action
2026-03-10
Official status
Signed by the Governor
Effective date
Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

  1. 2026-03-10 South Dakota Legislature

    Signed by the Governor

Official Summary Text

reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.